Group 4D: Inflammatory & Triple Negative Breast Cancer; Biomarkers; Clinical Trials; Immunotherapy

Poster #1098: Prognostic value of tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer (BC): A focus on inflammatory BC

Poster #1105: Biomarker analysis of phase II pembrolizumab maintenance treatment after chemotherapy response in patients with HER2-negative inflammatory breast cancer and triple-negative breast cancer